Literature DB >> 27578826

WOMEN IN CANCER THEMATIC REVIEW: Ovarian cancer-peritoneal cell interactions promote extracellular matrix processing.

C Ricciardelli1, N A Lokman2, M P Ween3, M K Oehler2,4.   

Abstract

Ovarian cancer has a distinct tendency for metastasising via shedding of cancerous cells into the peritoneal cavity and implanting onto the peritoneum that lines the pelvic organs. Once ovarian cancer cells adhere to the peritoneal cells, they migrate through the peritoneal layer and invade the local organs. Alterations in the extracellular environment are critical for tumour initiation, progression and intra-peritoneal dissemination. To increase our understanding of the molecular mechanisms involved in ovarian cancer metastasis and to identify novel therapeutic targets, we recently studied the interaction of ovarian cancer and peritoneal cells using a proteomic approach. We identified several extracellular matrix (ECM) proteins including, fibronectin, TGFBI, periostin, annexin A2 and PAI-1 that were processed as a result of the ovarian cancer-peritoneal cell interaction. This review focuses on the functional role of these proteins in ovarian cancer metastasis. Our findings together with published literature support the notion that ECM processing via the plasminogen-plasmin pathway promotes the colonisation and attachment of ovarian cancer cells to the peritoneum and actively contributes to the early steps of ovarian cancer metastasis.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  annexin A2; extracellular matrix; ovarian cancer; plasmin; tumour microenvironment

Mesh:

Year:  2016        PMID: 27578826     DOI: 10.1530/ERC-16-0320

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  6 in total

1.  Unique cellular interactions between pancreatic cancer cells and the omentum.

Authors:  Valerya Feygenzon; Shelly Loewenstein; Nir Lubezky; Metsada Pasmanic-Chor; Osnat Sher; Joseph M Klausner; Guy Lahat
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

2.  Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance.

Authors:  Carmela Ricciardelli; Noor A Lokman; Carmen E Pyragius; Miranda P Ween; Anne M Macpherson; Andrew Ruszkiewicz; Peter Hoffmann; Martin K Oehler
Journal:  Oncotarget       Date:  2017-03-14

3.  Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer.

Authors:  Katarzyna Aleksandra Kujawa; Ewa Zembala-Nożyńska; Alexander Jorge Cortez; Tomasz Kujawa; Jolanta Kupryjańczyk; Katarzyna Marta Lisowska
Journal:  Cells       Date:  2020-01-08       Impact factor: 6.600

4.  Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.

Authors:  Biying Guo; Huan Yan; Luying Li; Kemin Yin; Fang Ji; Shu Zhang
Journal:  J Ovarian Res       Date:  2017-10-11       Impact factor: 4.234

5.  Biomarkers of tumor invasiveness in proteomics (Review).

Authors:  Daniel L Pouliquen; Alice Boissard; Olivier Coqueret; Catherine Guette
Journal:  Int J Oncol       Date:  2020-05-28       Impact factor: 5.650

6.  Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.

Authors:  Masato Yoshihara; Hiroaki Kajiyama; Akira Yokoi; Mai Sugiyama; Yoshihiro Koya; Yoshihiko Yamakita; Wenting Liu; Kae Nakamura; Yoshinori Moriyama; Hiroaki Yasui; Shiro Suzuki; Yusuke Yamamoto; Carmela Ricciardelli; Akihiro Nawa; Kiyosumi Shibata; Fumitaka Kikkawa
Journal:  Int J Cancer       Date:  2020-01-24       Impact factor: 7.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.